Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
6
×
life sciences
national blog main
boston top stories
fda
boston
san francisco blog main
investing
san diego blog main
cancer
deals
dyne therapeutics
ipo
medical device
myotonic dystrophy type 1
national top stories
new york blog main
rare disease drugs
san diego top stories
480 biomedical
akouos
arsenal medical
astellas pharma
astellas pharmaceuticals
atlas venture
audentes therapeutics
avidity biosciences
biotech ipos
black diamond therapeutics
bladder cancer
bluebird bio
blueprint medicines
bob langer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
california institute for biomedical research
cancer drugs
What
ipo
6
×
therapeutics
6
×
drug
medicines
developing
million
new
raised
biotech
biotechs
companies
company
dyne
genetic
muscle
public
rare
treat
affects
ago
americans
approved
black
brings
cancer
clinic
club
considering
continued
crop
data
date
debut
diamond
diseases
disorders
dyne’s
early
eluded
exceeded
Language
unset
Current search:
ipo
×
therapeutics
×
" clinical trials "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M